Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-PSMA PET/CT in Prostate Cancer
NCT04684628Phase 3Suspended
- Sponsor
- University of Saskatchewan
- Start
- Dec 2020
- Primary completion
- Jan 2025
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 3 trial of gallium ga-68 gozetotide in prostate cancer (PCa), sponsored by University of Saskatchewan. Started Dec 2020; status: suspended.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04684628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684628.